Summary & Overview
HCPCS J7641: Flunisolide Inhalation Solution, Compounded for Nebulizer
HCPCS Level II code J7641 designates flunisolide inhalation solution as a compounded product billed per milligram when administered through durable medical equipment (DME). This code captures nebulized corticosteroid therapy provided as unit-dose formulations for patients requiring inhalation delivery, typically in home or outpatient settings. Nationally, accurate use of J7641 matters for capturing compounded respiratory drug utilization, managing pharmacy-DME billing interactions, and ensuring appropriate coverage and documentation for nebulized steroid therapy.
Key payers addressed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the code's clinical context and billing scope, followed by benchmarks and payer coverage considerations where available. The publication outlines common billing modifiers and administrative notes related to compounded inhalation products, reimbursement implications for DME-administered medications, and coding practices to support claims accuracy.
The material provides clinicians, coders, and revenue staff with practical context for when J7641 applies, how it integrates with DME services, and the typical sites of service. Data not available in the input is noted where relevant; the focus remains on national-level coding and billing interpretation rather than state-specific guidance.
Billing Code Overview
HCPCS Level II code J7641 describes flunisolide, inhalation solution, compounded product, administered through DME, unit dose, per milligram. This code represents a compounded inhalation corticosteroid formulation intended for aerosol delivery via durable medical equipment (DME) such as a nebulizer.
Service type: Respiratory pharmacologic therapy administered via DME
Typical site of service: Home or outpatient settings where nebulizer therapy is provided through durable medical equipment
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 52-year-old patient with a history of moderate persistent allergic asthma presents for medication management after inadequate symptom control with metered-dose inhalers and nebulized standard solutions. The clinician prescribes a compounded inhalation solution of flunisolide to be administered via a home respiratory device (durable medical equipment) that dispenses unit-dose medication. The outpatient workflow includes: initial evaluation by a pulmonologist or allergist; prescription of J7641 specifying milligram quantity per unit dose and frequency; coordination with a specialty pharmacy or compounding pharmacy that prepares the sterile inhalation solution; delivery of the compounded unit-dose vial(s) along with device training by a respiratory therapist or durable medical equipment supplier; documentation of indication, dose, lot numbers, and patient education in the medical record; and periodic follow-up visits to assess efficacy, inhaled corticosteroid side effects, and need for refill or dose adjustment.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier applicable (default) | Use when no specific modifier applies to the service. |